These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33247185)

  • 21. Magnetic resonance enhancement pattern and diagnostic accuracy of gadofluorine M in a rabbit VX2 tumor model: Comparison with gadopentetate dimeglumine.
    Kim SJ; Moon WK; Choi SH; Chang JM; Cho N
    Eur J Radiol; 2012 Aug; 81(8):1751-7. PubMed ID: 21477960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and characterization of primary liver cancer in rats by MS-264-enhanced MRI.
    Petré C; Ni Y; Marchal G; Yu J; Wevers M; Lauffer RB; Baert AL
    Magn Reson Med; 1996 Apr; 35(4):532-9. PubMed ID: 8992203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic MRI of a hypovascularized liver tumor model: comparison of a new blood pool contrast agent (24-gadolinium-DTPA-cascade-polymer) with gadopentetate dimeglumine.
    Tacke J; Adam G; Classen H; Mühler A; Prescher A; Günther RW
    J Magn Reson Imaging; 1997; 7(4):678-82. PubMed ID: 9243388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model.
    Runge VM
    Invest Radiol; 1998 May; 33(5):263-7. PubMed ID: 9609484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, characterization, and imaging performance of a new class of macrocyclic hepatobiliary MR contrast agents.
    Marinelli ER; Neubeck R; Song B; Wagler T; Ranganathan RS; Sukumaran K; Wedeking PW; Nunn A; Runge VM; Tweedle MF
    Invest Radiol; 2000 Jan; 35(1):8-24. PubMed ID: 10639032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field Strength.
    Fries P; Massmann A; Robert P; Corot C; Laschke MW; Schneider G; Buecker A; Müller A
    Invest Radiol; 2019 Sep; 54(9):549-558. PubMed ID: 31033675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic enhancement features of gadophrin-2 on magnetic resonance imaging: an experimental model of VX2 carcinoma and bacterial abscess in rabbit thigh.
    Ju Lee H; Kim IO; Kim TK; Hyung Kim S; Choi JI; Woo Lee J; Kyung Moon W; Choi BI; Chung Han M; Weinmann HJ; Hyun Chang K
    Invest Radiol; 2002 Dec; 37(12):663-71. PubMed ID: 12446999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors.
    Virmani S; Wang D; Harris KR; Ryu RK; Sato KT; Lewandowski RJ; Nemcek AA; Szolc-Kowalska B; Woloschak G; Salem R; Larson AC; Omary RA
    J Vasc Interv Radiol; 2007 Oct; 18(10):1280-6. PubMed ID: 17911519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments.
    Ni Y; Marchal G
    Top Magn Reson Imaging; 1998 Jun; 9(3):183-95. PubMed ID: 9621406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quantitative study of dynamic magnetic resonance perfusion-weighted imaging in rabbit models of implanted hepatic VX2 tumor].
    Quan XY; Zhang XL; Sun XJ; Xing HF; Liang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):620-2. PubMed ID: 16762866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatially resolved quantification of gadolinium(III)-based magnetic resonance agents in tissue by MALDI imaging mass spectrometry after in vivo MRI.
    Aichler M; Huber K; Schilling F; Lohöfer F; Kosanke K; Meier R; Rummeny EJ; Walch A; Wildgruber M
    Angew Chem Int Ed Engl; 2015 Mar; 54(14):4279-83. PubMed ID: 25689595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced ablation of high intensity focused ultrasound with microbubbles: an experimental study on rabbit hepatic VX2 tumors.
    He W; Wang W; Zhou P; Wang YX; Zhou P; Li RZ; Wang JS; Ahuja AT
    Cardiovasc Intervent Radiol; 2011 Oct; 34(5):1050-7. PubMed ID: 21127863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low contrast medium and radiation dose for hepatic computed tomography perfusion of rabbit VX2 tumor.
    Zhang CY; Cui YF; Guo C; Cai J; Weng YF; Wang LJ; Wang DB
    World J Gastroenterol; 2015 May; 21(17):5259-70. PubMed ID: 25954099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
    Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
    AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular imaging of extracellular matrix proteins with targeted probes using magnetic resonance imaging.
    Salarian M; Ibhagui OY; Yang JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1622. PubMed ID: 32126587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium mesoporphyrin as an MR imaging contrast agent in the evaluation of tumors: an experimental model of VX2 carcinoma in rabbits.
    Kim TK; Choi BI; Park SW; Lee W; Han JK; Han MC; Weinmann HJ
    AJR Am J Roentgenol; 2000 Jul; 175(1):227-34. PubMed ID: 10882277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent.
    von Bary C; Makowski M; Preissel A; Keithahn A; Warley A; Spuentrup E; Buecker A; Lazewatsky J; Cesati R; Onthank D; Schickl N; Schachoff S; Hausleiter J; Schömig A; Schwaiger M; Robinson S; Botnar R
    Circ Cardiovasc Imaging; 2011 Mar; 4(2):147-55. PubMed ID: 21378029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
    Runge VM; Lee C; Iten AL; Williams NM
    Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.